Sponsor or institution
Clinical trials and research at Virogenics, INC.
As of November 12, 2026, Find a Trial lists 5 NIH-funded research projects at this institution, with $7.1 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5NIH research projects
NIH-funded research (5)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
CMS121 long-term safety testing to support Alzheimer’s drug development
A non-clinical safety study in animals is planned to support advancing CMS121 for Alzheimer’s disease into a Phase 2 trial.
-
New drug CMS121 to help people with Alzheimer’s disease
A promising new drug candidate called CMS121 is being studied to support a long-term treatment plan for adults with mild to moderate Alzheimer’s disease.
-
Long-term safety testing of CMS121 for people with mild to moderate Alzheimer's disease
This project is testing whether the new pill CMS121 can be safely given every day for a long time to adults with mild to moderate Alzheimer's disease.
-
Developing a new treatment for Alzheimer's Disease
This study is testing a new drug called CMS121 that could help improve memory and thinking skills in people with Alzheimer's Disease, offering a different approach than current treatments, and it might make a real difference if it works well in trials.
-
Investigating a new treatment for Alzheimer's Disease
This study is testing a new drug called CMS121 to see if it can help people with mild to moderate Alzheimer's Disease by improving memory and thinking skills, while also making sure it's safe to take every day.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.